ReviewInternational journal of women's dermatology2026
Advancements in treating stretch marks across all skin types: a comprehensive review of therapeutic modalities.
Review in International journal of women's dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Striae distensae (SD) (stretch marks) are common dermal scars resulting from rapid skin stretching during puberty, pregnancy, or weight changes and disproportionately affect women. Management remains challenging, particularly in individuals with darker skin tones, due to variable efficacy and the risk of postinflammatory hyperpigmentation with certain therapies. Objective: To review current and emerging treatment modalities for SD across all Fitzpatrick skin types, with an emphasis on efficacy, safety, and the role of combination therapies. Methods: A comprehensive literature review was conducted using peer-reviewed clinical trials, observational studies, and dermatologic reviews evaluating topical, procedural, laser-based, and combination therapies for SD. Treatments were analyzed based on mechanism of action, clinical outcomes, skin type suitability, and reported adverse effects. Results: Topical tretinoin demonstrated modest efficacy dependent on concentration and treatment duration. Laser-based therapies, including ablative and nonablative fractional lasers, improved collagen remodeling and stretch mark appearance, with nonablative lasers showing better tolerability in darker skin types. Microneedling and fractional microneedling radiofrequency were effective and cost-efficient options across skin types. Combination therapies, particularly those integrating microneedling, radiofrequency, platelet-rich plasma, or fractional CO Limitations: Heterogeneity among studies, including inconsistent outcome measures, variable treatment protocols, and limited long-term follow-up, restricts direct comparison of therapeutic efficacy. Additionally, many studies included small sample sizes and lacked standardized assessment tools such as a uniform visual analog scale and Dermatology Life Quality Index scoring. Conclusion: Multiple therapeutic options exist for the management of SD, with treatment selection influenced by striae stage and Fitzpatrick skin type. Combination therapies demonstrate the most promising results, particularly for treatment-resistant striae alba and patients with darker skin tones. Standardization of outcome measures and further high-quality comparative studies are needed to optimize individualized treatment strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.